Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Moore Blog

BOD bashers-Is this what you want?

in response to by
posted on Dec 28, 2009 09:15AM

On Monday December 28, 2009, 7:58 am EST

(Reuters) - Amicas Inc (NasdaqGM:AMCS - News), a provider of healthcare IT services, said it agreed to be bought by an affiliate of private firm Thoma Bravo LLC for $217 million in an all-cash deal.

The deal offers Amicas shareholders $5.35 for each share, a premium of 21 percent over the stock's close on December 24 on Nasdaq.

Amicas expects to close the transaction in the first quarter of 2010, it said in a statement.

Shares of the Boston, Massachusetts-based company closed at $4.42 Thursday.

Share
New Message
Please login to post a reply